123 related articles for article (PubMed ID: 7605434)
41. [Diagnosis of human parvovirus B19].
Tajima M
Nihon Rinsho; 1999 Nov; 57 Suppl():286-90. PubMed ID: 10635836
[No Abstract] [Full Text] [Related]
42. Parvovirus B19 DNA contamination in coagulation factor VIII products.
Eis-Hübinger AM; Sasowski U; Brackmann HH
Thromb Haemost; 1999 Mar; 81(3):476-7. PubMed ID: 10102490
[No Abstract] [Full Text] [Related]
43. HIV infection and haemophilia.
Jones P
Arch Dis Child; 1991 Mar; 66(3):364-8. PubMed ID: 1902651
[No Abstract] [Full Text] [Related]
44. Infection au parvovirus B19 pendant la grossesse.
Crane J; Mundle W; Boucoiran I
J Obstet Gynaecol Can; 2016 Dec; 38(12S):S525-S536. PubMed ID: 28063562
[No Abstract] [Full Text] [Related]
45. HIV infection. UK haemophiliacs win compensation.
Aldhous P
Nature; 1990 Dec 20-27; 348(6303):667. PubMed ID: 2124331
[No Abstract] [Full Text] [Related]
46. Self limiting lupus-like symptoms in patients with parvovirus B19 infection.
Tóvári E; Mezey I; Hedman K; Czirják L
Ann Rheum Dis; 2002 Jul; 61(7):662-3. PubMed ID: 12079921
[No Abstract] [Full Text] [Related]
47. [Hematological significance of parvovirus B19 infection].
Schwarz TF; Jäger G
Dtsch Med Wochenschr; 1993 Jun; 118(23):873-8. PubMed ID: 8508734
[No Abstract] [Full Text] [Related]
48. [Transmission of parvovirus B19 by blood and blood components].
Schwarz TF
Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():27-31. PubMed ID: 8000251
[TBL] [Abstract][Full Text] [Related]
49. [Parvovirus B19 infection in different shapes. But more laboratories have refined the diagnostic methods].
Jorup C; Gyllensten K; Persson A; Forsgren M; Sönnerborg A
Lakartidningen; 1995 Nov; 92(46):4331-4. PubMed ID: 7490957
[No Abstract] [Full Text] [Related]
50. Comparison of two pharmacokinetic techniques for individualizing factor VIII dosage in haemophilia patients.
Morfini M; Grasela TH; Longo G; Matucci M; Messori A; Vannini S; Rossi-Ferrini P
Haematologica; 1985; 70(5):454-6. PubMed ID: 3937784
[No Abstract] [Full Text] [Related]
51. Treatment of haemophilia A with fraction 1-0.
Pitney WR
Bibl Haematol; 1965; 23():1314. PubMed ID: 5885222
[No Abstract] [Full Text] [Related]
52. Treatment of haemophilia A with purified factor 8 obtained from human plasma by cryoprecipitation.
Meyer K; Eernisse JG; Veltkamp JJ; Hemker HC; Loeliger EA
Folia Med Neerl; 1967; 10(2):49-60. PubMed ID: 6039247
[No Abstract] [Full Text] [Related]
53. Doubly virus-inactivated factor VIII concentrate in haemophilia A.
Chacon JM; Quintana R; Iruin G; Aragües P; Corral J
Lancet; 1993 Sep; 342(8871):626. PubMed ID: 8102762
[No Abstract] [Full Text] [Related]
54. Treatment of haemophilia.
Br Med J; 1967 Apr; 2(5544):65-6. PubMed ID: 6020849
[No Abstract] [Full Text] [Related]
55. Treatment of haemophilia with purified factor 8 (FI-O-Ta).
de Tezanos Pinto M
Hemostase; 1966; 6(1):65-71. PubMed ID: 5911788
[No Abstract] [Full Text] [Related]
56. Parvovirus B19 outbreak on an adult ward.
Seng C; Watkins P; Morse D; Barrett SP; Zambon M; Andrews N; Atkins M; Hall S; Lau YK; Cohen BJ
Epidemiol Infect; 1994 Oct; 113(2):345-53. PubMed ID: 7925671
[TBL] [Abstract][Full Text] [Related]
57. [Liver cancer in male hemophiliacs].
Flahault A
Rev Epidemiol Sante Publique; 1998 Mar; 46(2):148-9. PubMed ID: 9592858
[No Abstract] [Full Text] [Related]
58. Human parvovirus B19 infection within a family and risk for pregnant women.
Azzi A; Trotta M; Zakrzewska K; Balzer E; Rogasi PG; Carocci A; Leoncini F
Epidemiol Infect; 1996 Oct; 117(2):401-3. PubMed ID: 8870639
[TBL] [Abstract][Full Text] [Related]
59. Human parvovirus B19 after concentrates for haemophilia.
Di Napoli G; Bucci E
Lancet; 1994 Jun; 343(8912):1566. PubMed ID: 7911884
[No Abstract] [Full Text] [Related]
60. Quantitation of human parvovirus B19 DNA by real-time polymerase chain reaction.
Takano T; Yamada K
Pediatr Int; 2007 Aug; 49(4):459-62. PubMed ID: 17587268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
